Australia markets closed

Venn Life Sciences Holdings Plc (CRO.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.28000.0000 (0.00%)
As of 09:43AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
56,043
56,043
48,477
36,864
20,602
Cost of revenue
24,170
-
-
963
727
Gross profit
31,873
-
-
35,901
19,875
Operating expenses
Selling general and administrative
24,170
24,170
23,260
20,220
10,962
Total operating expenses
45,722
45,722
42,335
36,568
28,485
Operating income or loss
10,321
10,321
6,142
296
-8,610
Interest expense
155
155
133
227
374
Income before tax
11,147
11,147
-365
277
-10,980
Income tax expense
-4,968
-4,968
411
351
-189
Income from continuing operations
16,115
16,115
-776
-74
-10,791
Net income
16,115
16,115
-776
-74
-10,791
Net income available to common shareholders
16,115
16,115
-776
-74
-10,791
Basic EPS
0.00
0.02
-0.00
-0.00
-0.02
Diluted EPS
0.00
0.02
-0.00
-0.00
-0.02
Basic average shares
673,017
677,444
670,944
670,187
599,920
Diluted average shares
673,017
685,847
670,944
670,187
599,920